Patent · US Active

Heterocyclic compound

US11236099B2 · kind B2 · utility

2Cited by

21References

22Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Kazuaki Takami · Yokohama, JP
Masaki Seto · Yokohama, JP
Shinobu Sasaki · Yokohama, JP
Haruhi Ando · Yokohama, JP
Masaki Ogino · Yokohama, JP
Tomoko Ohashi · Yokohama, JP
Toshihiro Imaeda · Yokohama, JP
Ikuo Fujimori · Yokohama, JP
Yasuhiro Tsukimi · Kasai, JP
Masami Yamada · Yokohama, JP
Kenichiro Shimokawa · Yokohama, JP
Takeshi Wakabayashi · Fujisawa, JP
Masataka Murakami · Osaka, JP
Makoto Fushimi · Yokohama, JP
Tomohiro Okawa · Yokohama, JP
Jinichi Yonemori · Yokohama, JP
Tomohiro Ohashi · Yokohama, JP
Hideo Suzuki · Wakayama, JP
Hironobu Maezaki · Yokohama, JP
Ayumu Sato · Yokohama, JP
Yasutomi Asano · Yokohama, JP
Steve Swann · San Diego, US

Key dates

Filing date	Jun 19, 2018
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Jun 19, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention aims to provide a compound that may be useful for the prophylaxis or treatment of constipation and the like. The present invention provides a compound represented by the following formula (I): wherein each symbol is as described in the specification, or a salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.